Clive Davis, the record executive whose ear for talent and willingness to bet on it redrew the commercial map of American popular music, died on June 22, 2026, at his Manhattan apartment. He was 94. AP News reported he had been hospitalized for an upper respiratory issue prior to his death.

Davis arrived in the music industry as an unlikely figure: a corporate lawyer with no particular background in A&R or artist development. That outsider's detachment may have been an asset. Where career record men often chased genre orthodoxies, Davis listened for commercial potential across format lines — a habit that earned him the industry sobriquet "the man with the golden ear," as Reuters noted.

The scope of his signings tracks the arc of postwar American popular music. Among the artists he brought into the catalog were Bruce Springsteen and Billy Joel — two figures who, for a generation of listeners, became near-synonymous with a certain strain of working-class rock storytelling. Neither was a guaranteed commercial proposition at signing; both became catalogue anchors that generated revenue across decades.

The roster is, in itself, a kind of argument. Signing Springsteen and Joel was not pattern-matching to an established hit formula; it was an idiosyncratic read on what would connect with audiences that had not yet fully formed. Executives who work at that level — moving before consensus, not after — are genuinely scarce in any era of the music business, and Davis worked across several of them, from the album-rock consolidation of the late 1960s through the streaming disaggregation of the 2010s.

The music industry he navigated for six decades is structurally different from the one that will memorialize him. Physical unit sales, the profit engine that underwrote the A&R budgets Davis commanded, have been largely displaced by streaming royalties distributed across catalogs of millions. The leverage that once resided with label executives who controlled distribution and marketing spend now sits elsewhere — with playlist curators, algorithmic recommendation systems, and the artists themselves, who can release directly. Whether a career like Davis's is reproducible in that environment is a structural question the industry has not resolved.

What the record does show is that his model — signing artists before the market had priced them, then investing in development over multiple album cycles — produced durable commercial and cultural value. That approach required patient capital and institutional risk tolerance that defined the major-label system at its peak. The conditions that made it possible are considerably narrower now.

Davis is survived by the catalog he built, which will continue to generate revenue and litigated rights disputes long after the tributes have cycled through. In the music business, that kind of longevity is its own form of obituary.